RCM
ENZ

RA Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

RA Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,268,653
Closed -$6.62M – 38
2013
Q4 		$6.62M Sell
2,268,653
-1,079,376
-32% -$2.68M 0.77% 25
2013
Q3 		$8.44M Hold
3,348,029
– – 0.88% 27
2013
Q2 		$6.96M Buy
+3,348,029
New +$7.39M 0.92% 22

Other funds holding ENZ

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
PRC
Platte River Capital Denver, Colorado $108M AUM 0.26% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

RA Capital Management's ENZ Position: Q1 2014 in Review

RA Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2014, closing a stake of 2,268,653 shares — an estimated $6.62M sold.

RA Capital Management first reported a position in ENZ in Q2 2013 and held it in 3 quarters. The position peaked at $8.44M in Q3 2013. 63 funds tracked by Wall St. Rank hold ENZ as of Q1 2014.

  • RA Capital Management reported no remaining Enzo Biochem, Inc. position as of Q1 2014 after selling out during the quarter.
  • RA Capital Management sold 2,268,653 Enzo Biochem, Inc. shares in Q1 2014, an estimated $6.62M.
  • RA Capital Management first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 3 quarters.
  • RA Capital Management's Enzo Biochem, Inc. position peaked at $8.44M in Q3 2013.
  • 63 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2014.

Based on RA Capital Management's 13F filing for Q1 2014, filed 15 May 2014.